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Abstract
Background: Escherichia coli MutY (EcMutY) reduces mutagenesis by removing adenines paired
with guanines or 7,8-dihydro-8-oxo-guanines (8-oxoG). V45 and Q182 of EcMutY are considered
to be the key determinants of adenine specificity. Both residues are spatially close to each other in
the active site and are conserved in MutY family proteins but not in Methanobacterium
thermoautotrophicum Mig.MthI T/G mismatch DNA glycosylase (A50 and L187 at the corresponding
respective positions).
Results: Targeted mutagenesis study was performed to determine the substrate specificities of
V45A, Q182L, and V45A/Q182L double mutant of EcMutY. All three mutants had significantly
lower binding and glycosylase activities for A/G and A/8-oxoG mismatches than the wild-type
enzyme. The double mutant exhibited an additive reduction in binding to both the A/G and A/GO
in comparison to the single mutants. These mutants were also tested for binding and glycosylase
activities with T/G- or T/8-oxoG-containing DNA. Both V45A and Q182L mutants had
substantially increased affinities towards T/G, however, they did not exhibit any T/G or T/8-oxoG
glycosylase activity. Surprisingly, the V45A/Q182L double mutant had similar binding affinities to T/
G as the wild-type EcMutY. V45A, Q182L, and V45A/Q182L EcMutY mutants could not reduce the
G:C to T:A mutation frequency of a mutY mutant. Expression of the V45A mutant protein caused
a dominant negative phenotype with an increased G:C to A:T mutation frequency.
Conclusion: The substrate specificities are altered in V45A, Q182L, and V45A/Q182L EcMutY
mutants. V45A and Q182L mutants had reduced binding and glycosylase activities for A/G and A/
8-oxoG mismatches and increased affinities towards T/G mismatch. However, in contrast to a
previous report that Mig.MthI thymine DNA glycosylase can be converted to a MutY-like adenine
glycosylase by replacing two residues (A50V and L187Q), both V45A and Q182L EcMutY mutants
did not exhibit any T/G or T/8-oxoG glycosylase activity. The dominant negative phenotype of
V45A EcMutY mutant protein is probably caused by its increased binding affinity to T/G mismatch
and thus inhibiting other repair pathways.
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Background
Reactive oxygen species are generated by endogenous
processes such as mitochondrial oxidative phosphoryla-
tion as well as exogenously following exposure to ionizing
radiation and chemicals [1]. Oxidative DNA damage
including strand breaks and oxidative base lesions are spe-
cifically repaired by base excision repair pathways [2]. The
first step in this pathway is carried out by a lesion-specific
DNA glycosylase, which cleaves the N-glycosidic bond
between the base and deoxyribose sugar [3]. The most
abundant and highly mutagenic oxidative DNA damage
lesion is 8-oxo-7,8-dihydroguanine (8-oxo-G or GO) that
can form base-pair with adenine or cytosine during DNA
replication to produce a G:C to T:A transversion [4,5]. In
Escherichia coli, MutT, MutM (Fpg), MutY, MutS, and Nei
(End VIII) are involved in defending against the muta-
genic effects of 8-oxoG lesions [reviewed in [6] and [4].
The MutT protein has pyrophosphohydrolase activity,
which eliminates 8-oxo-dGTP from the nucleotide pool.
MutM glycosylase (Fpg protein) removes both mutagenic
GO adducts and ring-opened purine lesions paired with
cytosines. MutS and MutY increase replication fidelity by
removing the adenines misincorporated opposite GO or
G [5,7,8], and thus reduce G:C to T:A transversions. Nei
can excise GO, when GO is paired opposite a cytosine or
adenine and can serve as a backup pathway to repair 8-
oxoG in the absence of MutM and MutY [6,9].
Unlike most DNA glycosylases, MutY does not target a
damaged base, but a normal base, e.g., removing A mis-
paired with GO, C, and 5-hydroxyuracil [reviewed in [4]].
In addition, MutY can excise guanines from G/GO mis-
matches [5]. MutY also binds tightly to DNA containing T/
GO and C/GO, however, it exhibits no catalytic activity on
them [10]. The N-terminal domain of EcMutY retains the
catalytic activity [10-14] while the C-terminal domain of
MutY plays an important role in the recognition of GO
lesions [10,11,14,15]. The X-ray crystal structures of
EcMutY catalytic domain with bound adenine [16] and
intact Bacillus stearothermophilus MutY (Bs-MutY) bound
to DNA [17] show that MutY distorts the bound DNA sub-
strate and the mismatched A is flipped out of the helix. In
the active site pocket of EcMutY, seven amino acids (R19,
E37, L40, N140, Q182, M185, and D186) are involved in
adenine binding (filled circles in Figure 1) [16]. V45 and
Q182 of EcMutY are proposed to be key residues in deter-
mining substrate specificity. V45 is considered to be
important for glycosylase activity because V45N is inactive
[16] and is conserved among MutY family members (Fig-
ure 1). Q182 forms a hydrogen bond with adenine at the
domain interface of EcMutY, but is less conserved [18].
The N-terminal domain of MutY shares similar structure,
including the helix-hairpin-helix (HhH) and Gly/Pro Asp
loop motifs (Figure 1), with AlkA, EndoIII, and OGG1.
The G/T mismatch glycosylase Mig.MthI of Methanobacte-
rium thermoautotrophicim is a member of the HhH super-
family [19] and is involved in reducing spontaneous
deaminated bases from 5-methyl-cytosine residues. The
substrate specificity of Mig.MthI is in the order: U/G = T/
G > G/G > T/C = U/C > A/G. In the binding pocket for the
target base, Mig.MthI shares six out of seven residues of
EcMutY's adenine binding (R19, E37, L40, N140, Q182,
M185, and D186). The only non-conserved residue in this
binding pocket is Q182 of EcMutY, which corresponds to
L187 of Mig.MthI (Figure 1). Interestingly, Fondufe-Mit-
tendorf et al. [20] could convert Mig.MthI into a MutY-like
glycosylase with altered substrate preference of Mig.MthI
from T/G to A/G by replacing two residues (A50V and
L187Q) in the substrate binding pocket. Their data point
to the potential importance of V45 and Q182 in EcMutY
substrate recognition.
In this study, we have investigated the role of V45 and
Q182 of EcMutY by targeted mutagenesis. V45A, Q182L,
and V45A/Q182L mutant proteins have reduced binding
affinity and glycosylase activity to DNA containing A/G or
A/GO mismatches. These mutants are impaired to com-
plement E. coli mutY mutants in vivo. The affinities to T/G
dramatically increased in V45A and Q182L mutants, but
not in the V45A/Q182L double mutant. However, V45A,
Q182L, and V45A/Q182L mutant proteins do not exhibit
glycosylase activity towards T/G or T/GO. Therefore, V45
and Q182 of EcMutY are important for the adenine-spe-
cific activity of EcMutY.
Results and discussion
Selection of EcMutY mutation
The study by Fondufe-Mittendorf et al. [20] indicates that
the substrate preference of Mig.MthI can be altered from
T/G to A/G by replacing two residues (A50V and L187Q)
in the substrate binding pocket. Their results are in agree-
ment that V45 and Q182 of EcMutY are the key determi-
nants of adenine specificity [16]. According to the adenine
soaked EcMutY structure (Figure 2A) [16], V45 is located
in the minor-groove reading α2–α3 motif (37-EVM-
LQQTQV-45) and Q182 is located in the adenine recogni-
tion  α10 motif (182-QAMMD-186). Interestingly, the
proximity of V45 and Q182 to adenine in EcMutY struc-
ture closely correlates with the BsMutY structure with the
DNA product and cleaved adenine [17]. However, the res-
idues corresponding to Val45 and Gln182 in D144N
BsMutY with A/GO-containing DNA (so called the lesion
recognition complex) [17] do not directly make contacts
with the adenine of the A/GO mismatch. In the later struc-
ture, the Val seems to be positioned below the adenine,
but the Glu188 of BsMutY (corresponding to Glu182 of
EcMutY) is far away from adenine. The fact that there are
differences in adenine recognition among various MutY
structures raises a question whether these residues reallyBMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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are involved directly in adenine recognition. To determine
whether these two residues are important for adenine rec-
ognition and excision, we carried out targeted mutagene-
sis study to determine the effect of EcMutY V45A, Q182L,
and double mutant on repair of A/G- and A/GO-contain-
ing DNA. We also further determined whether their sub-
strate specificity is altered in terms of binding or catalysis
of T/G or T/GO mismatches.
A/G and A/GO binding and glycosylase activity
We compared the binding affinities of V45A, Q182L, and
V45A/Q182L double mutants with wild-type EcMutY to
DNA substrates containing A/G and A/GO mismatches.
First, we determined the active site concentrations of these
proteins by performing A/GO binding with DNA concen-
trations which are at least 17-fold higher than their esti-
mated dissociation constants (Kd). Figure 3 shows the
average results from two independent experiments with 8
nM of A/GO-DNA. The increase in wild-type (WT)
EcMutY binding reached a maximum at a concentration
about 25 nM of MutY and 5.44 nM DNA was bound (68%
of 8 nM). This horizontal line intercepts with the slope
line of initial rate at 8 nM of MutY. Thus, the WT EcMutY
preparation is 68% active. Similar analyses showed that
V45A, Q182L, and V45A/Q182L were 48%, 25%, and
40% active, respectively. Dissociation constant value for
each mutant was determined with nine enzyme concen-
trations by at least three independent experiments (Table
1). Because MutY displays a high affinity for its products
[21], the Kd values measure its affinities to a mixture of the
substrate and the product. Compared to wild-type EcMutY
of which the Kd to A/G is 1.3 ± 0.11 nM, the V45A and
Q182L mutants had Kd values of 6.1 ± 1.7 and 8.9 ± 5.0
nM, respectively. The Kd value (15 ± 2 nM) of V45A/
Q182L double mutant was higher than the single
mutants. Thus, the affinities to A/G of V45A, Q182L, and
V45A/Q182L are weakened by 5-, 7-, and 12-fold, respec-
tively. For A/GO binding, V45A and Q182L mutations
resulted in a 94- and 11-fold increase in Kd values, respec-
tively. The V45A/Q182L double mutation resulted in a
Sequence Alignment Figure 1
Sequence Alignment. The protein sequences of B. stearothermophilus MutY (1VRLA, BsMutY), E. coli MutY (AP 003518, 
EcMutY), T. thermophilus MutY (YP 145164, TthMutY), and M. thermoautotrophicum Mig.MthI (P 29588, Mig) were aligned using 
ClustalW algorithm. The open and shadowed boxes represent conserved and identical residues respectively. The two residues 
subjected to mutation in this study are shaded in black. The highly conserved HhH-GPD motif is indicated. Filled circles indi-
cate EcMutY residues involved in adenine binding and stars indicate Mig.Mth1 residues important for thymine recognition. The 
hollow circle and triangle mark the base flipper and the conserved catalytic Asp, respectively.BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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102-fold increase in Kd value (i.e. 102-fold weaker binding
affinity). Thus, V45A is more defective in A/GO binding
than A/G binding as compared to wild-type MutY. It is
interesting to note that the double mutant exhibited an
additive reduction in binding to both the A/G and A/GO
as for the single mutants. These results confirm that V45
and Q182 play important but independent roles in ade-
nine binding.
Because V45A and Q182L EcMutY mutants showed weak-
ened A/G and A/GO affinities, we examined their glycosy-
lase activities on A/G and A/GO (Figure 4). V45A mutant
showed decrease in A/G glycosylase activity at 0.48 and
4.8 nM concentrations (Figure 4A, lanes 4–5) while
Q182L mutant showed no activity at 0.25 nM and
decrease in activity at 2.5, and 12.5 nM (Figure 4A, lanes
7–9), as compared to wild-type MutY. The glycosylase
activity of V45A/Q182L mutant on A/G was nearly unde-
tectable at 20 nM (Figure 4A, lane 12). With A/GO sub-
strate, both V45A and Q182L mutants showed decrease in
activity at 0.48 and 0.25 nM, respectively (Figure 4B, lanes
4 and 7), whereas the V45A/Q182L double mutant
(A). E. coli MutY structure bound to adenine base (RCSB ID 1MUD) with thymine docked into the binding pocket as proposed  by Mol et al. [23] for Mig.MthI Figure 2
(A). E. coli MutY structure bound to adenine base (RCSB ID 1MUD) with thymine docked into the binding 
pocket as proposed by Mol et al. [23] for Mig.MthI. The residues of EcMutY known to be important for adenine recogni-
tion (E37, V45, and Q182) and the adenine and thymine bases are colored by atom type except the carbons in the docked 
thymine are colored yellow. Residues homologous to those residues in Mig.MthI proposed to be important in forming a hydro-
phobic pocket around the thymine methyl group (marked Me) are colored yellow. (B). The active site of Mig.MthI with thymine 
docked in according to the proposed orientation and hydrogen-bonding scheme [23]. The adenine from the EcMutY structure 
is included as a reference to show the relative position of key residues in the active site. As in (A), residues implicated in solvat-
ing the thymine methyl group are colored yellow. Y126, which is proposed to form a hydrogen bond with O2 of thymine is not 
pictured for reasons of clarity. (C). A space-filling model of thymine docked into the EcMutY active site, with an emphasis on 
interactions with the methyl group (Me). (D). A space-filling model of thymine docked into the Mig.MthI active site as proposed 
[23].BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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showed no activity at 0.4 nM and decreased activity at 4,
and 20 nM (Figure 4B, lane 10–12). The glycosylase activ-
ity assayed at the indicated active site concentrations is
based on the active site titration results upon binding with
A/GO-DNA. Since the mutants' glycosylase activities are
affected differently from DNA binding, thus, the active
site concentrations measured by DNA binding may be dif-
ferent from those measured by DNA glycosylase activity.
We also used single-turnover glycosylase kinetics with
enzyme in excess over DNA (time-course study) to com-
pare the activities of wild-type and mutant EcMutY pro-
teins. As shown in Figure 5, the rates of cleavage on both
A/G- and A/GO-containing DNA by MutY-V45A were
only slightly lower than those of the wild-type EcMutY
protein. However, the rates of cleavage of both A/G- and
A/GO-containing DNA were much lower for Q182L and
V45A/Q182L mutants than those of the wild-type EcMutY
(Figure 5). The rate constants (k2) of Q182L and V45A/
Q182L mutants with A/G mismatch at 37°C were 0.025 ±
0.016 Min-1 and 0.032 ± 0.026 Min-1, respectively, and
were about 10-fold lower that that of the wild-type
EcMutY (with k2 of 0.24 ± 0.03 Min-1) (Table 2). The k2 of
Q182L and V45A/Q182L mutants with A/GO mismatch
at 4°C were 0.16 ± 0.02 Min-1 and 0.37 ± 0.05 Min-1,
respectively, and were about 10-fold lower that that of the
wild-type EcMutY (with k2 of 2.4 ± 0.3 Min-1) (Table 2).
These results indicate that the overall repairing ability is
reduced by Q182L and V45A/Q182L mutants but not by
the V45A mutant. The above results demonstrate that
V45A and Q182L mutations have significant effect on
binding and glycosylase activities to A/G and A/GO mis-
pairs. A catalytic domain of EcMutY with a V45N muta-
tion has been shown to be inactive [16]. These results
indicate that V45 and Q182 are significant for the ade-
nine-specific activity of EcMutY.
T/G and T/GO binding and glycosylase activity
We next measured the T/G and T/GO binding affinities of
these mutants. Wild-type EcMutY showed a comparatively
high Kd (14 ± 1 nM) with a T/G mismatch (Table 1), how-
ever, this value is much lower than that of EcMutY with
C:G homoduplex (315 ± 49 nM) [22]. The Kd values of
V45A and Q182L mutants to T/G drastically decreased to
0.011 ± 0.004 nM and 0.043 ± 0.014 nM, representing a
1273 and 326-fold increase in binding affinity, respec-
tively (Table 1). Surprisingly, V45A/Q182L double
mutant showed a Kd value of 8.4 ± 0.7 nM, which is close
to that of wild-type EcMutY. The geometry or architecture
of the substrate binding pocket in the V45A/Q182L dou-
ble mutant may not favor thymine binding. For T/GO
binding, V45A, Q182L, and V45A/Q182L mutants
showed similar Kd values as wild-type EcMutY (Table 1),
indicating that the T/GO binding affinity of EcMutY does
not involve V45 and Q182. This result is consistent with
the findings of Li et al. [10] that tight T/GO binding is con-
trolled by the C-terminal domain of EcMutY.
Active site titration of wild-type EcMutY by binding to A/ GO-containing DNA Figure 3
Active site titration of wild-type EcMutY by binding 
to A/GO-containing DNA. DNA binding was assayed 
with 8 nM of A/GO-containing DNA and 2 to 200 nM (as 
measured by Bradford assay) of MutY. The result shows the 
average for two independent experiments. Calculated per-
centage bound were plotted as a function of EcMutY concen-
tration and fitted by a modified version of Eq. 2 except 
[P]active is replaced with protein concentration determined by 
Bradford assay. The increase in wild-type (WT) EcMutY 
binding reached a maximum at a concentration about 20 nM 
of MutY and 5.44 nM DNA was bound (68% of 8 nM). This 
line (horizontal dotted line) intercepts with the slope line of 
initial rate (slant dotted line) at 8 nM of EcMutY. Thus, the 
WT EcMutY preparation is 68% active.
Table 1: Apparent dissociation constants (Kd) of MutY mutants.
DNA WT V45A Q182L V45A/Q182L
A/G 1.3 ± 0.11a 6.1 ± 1.7 (0.21)b 8.9 ± 5.0 (0.15) 15 ± 2 (0.09)
A/GO 0.0048 ± 0.0029 0.45 ± 0.06 (0.01) 0.051 ± 0.009 (0.09) 0.59 ± 0.12 (0.01)
T/G 14 ± 1 0.011 ± 0.004 (1273) 0.043 ± 0.014 (326) 8.4 ± 0.7 (1.7)
T/GO 0.036 ± 0.013 0.024 ± 0.009 (1.5) 0.088 ± 0.061 (0.41) 0.013 ± 0.008 (2.77)
a Kd values (nM) are mean ± standard deviation for more than three experiments using nine protein concentrations.
bThe numbers in parenthesis are the folds of binding affinity relative to wild-type (WT) MutY.BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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Because Mig.MthI T/G glycosylase can be converted to an
A/G glycosylase by replacing two residues (A50V and
L187Q) [20], we examined the glycosylase activities of
Vl45A, Q182L, and V45A/Q182L on T/G and T/GO. None
of the EcMutY mutants showed any T/G and T/GO glyco-
sylase activity at enzyme concentration up to 1 μM under
different buffers and temperatures (data now shown).
Therefore, recognition and glycosylase of EcMutY mutants
to T/G and T/GO are controlled by different mechanisms.
The previous success to mutate Mig.MthI into MutY-like
enzyme [20] is in contrast to our failure to covert EcMutY
to thymine glycosylase. It is possible that it is easier to cat-
alyze adenine removal than thymine excision. It is inter-
esting to point out that wild-type Mig.MthI is a weak
adenine glycosylase and Mig.MthI with A50V/L187Q
mutation becomes a stronger adenine glycosylase. How-
DNA glycosylase activities of EcMutY mutants Figure 4
DNA glycosylase activities of EcMutY mutants. 1.8 
fmol (0.18 nM) of 3'-end labeled A/G- (panel A) or A/GO- 
(panel B) containing 44-mer oligonucleotides were incubated 
with three concentrations (1, 10, and 50 nM based on Brad-
ford assay) of EcMutY at 37°C for 30 min. With the active 
site titration assay upon binding with the A/GO-DNA, the 
active enzyme concentrations in the experiments are indi-
cated as following. Lanes 1–3, wild-type (WT) EcMutY at 
0.68, 6.8, and 34 nM were added. Lanes 4–6, V45A EcMutY 
at 0.48, 4.8, and 24 nM were added. Lanes 7–9, Q182L 
EcMutY at 0.25, 2.5, and 12.5 nM were added. Lanes 10–12, 
V45A/Q182L EcMutY at 0.4, 4, and 20 nM were added. After 
the reaction, the products were treated with 0.1 M NaOH 
and heated at 90°C for 30 min, followed by resuspension in 
formamide dye, and fractionated on a 14% denaturing 
sequencing gel. Arrows indicate the positions of intact oligo-
nucleotide (I) and the nicked product (N).
Time course studies of EcMutY mutant glycosylase activities Figure 5
Time course studies of EcMutY mutant glycosylase 
activities. Panel A, A/G-containing DNA substrate (0.18 
nM) was incubated with 49, 35, 18, and 29 nM of active site 
concentrations (all are 72 nM by Bradford assay) of WT, 
V45A, Q182L, and V45A/Q182L EcMutY, respectively, for 
various times at 37°C. Panel B is similar to panel A except 
that A/GO-containing DNA substrate (0.18 nM) was incu-
bated with EcMutY for various times at 4°C. After reaction, 
the products were immediately frozen at -70°C in the pres-
ence of 0.1 N NaOH, heated at 90°C for 30 min, supple-
mented with 5 μl formamide dye, and loaded onto 14% 7 M 
urea sequencing gels. Numerical data were obtained from 
PhosphorImager quantitative analyses of gel images over 
three experiments. Percentages of DNA cleaved were plot-
ted as a function of time.BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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ever, wild-type EcMutY has no thymine glycosylase activ-
ity and V45A/Q182L mutant may be harder to gain this
activity. In addition, the active site of Mig.MthI is more
relaxed for both purine and pyrimidine excision while
MutY is more strict to excise purines. The difference in the
base removal by these two enzymes may be contributed
by other residues surrounding the active site.
By aligning MutY and Mig.MthI sequences (Figure 1) and
inspecting the structures of Mig.MthI [23], EcMutY cata-
lytic domain [16] with docked thymine (Figure 2), we pre-
dicted that several residues may contribute to their
difference in activities. The thymine docked into the
EcMutY active site preserves the proposed edge-on hydro-
gen bonding interaction with the conserved glutamate
(E37, E42 in Mig.MthI) and can support a potential
hydrogen bond with a tyrosine in a potential S120Y
mutant (Figure 2A). It is clear from Figs. 2C and 2D that
the MutY active site poorly accommodates the methyl
group of thymine relative to the Mig.MthI active site. In
the present study, one important mutation (Q182L) has
been created. Based on our observations and the models
shown in Figure 2, the subsequent mutations most likely
to promote the conversion of MutY into a thymine glyco-
sylase would be Q25R and L22F. These two mutations
would complete the methyl-binding pocket and stabilize
the interaction with thymine. In addition, an S120Y muta-
tion, which would provide an additional hydrogen bond
(i.e. to the O2 of thymine) might further enhance any
thymine glycosylase activity resulting from the Q182L,
Q25R, and L22F mutations. However, such predictions
highlight the difficulty inherent in designing proteins
with novel activities. In particular, it has been shown that
Y126S mutation of Mig.MthI inactivates T/G mismatch-
specific glycosylase activity [23], however, the presence of
Tyr in BsMutY indicates that Tyr may not be the only key
residue for T/G catalytic activity. Similarly, BsMutY con-
tains R31 to accommodate the methyl group of thymine
relative to the Mig.MthI active site, but does not excise
thymine.
Recently, a bifuncional MutY-like glycosylase, TthMutY,
has been shown to have strong A/GO and G/GO activities,
comparatively weak T/GO and A/G activities, and no T/G
glycosylase activity [24]. Unlike Mig.MthI, TthMutY and
EcMutY contain extra C-terminal domains which facilitate
their recognition of the mispaired GO base. V42 and
Q170 of TthMutY are identical with the corresponding
residues in EcMutY (V45 and Q182) but different from
A50 and L187 of Mig.MthI (Figure 1). Although TthMutY
has weak T/GO glycosylase activity, its L19 and Q39 resi-
dues, which correspond to F27 and R47 of Mig.MthI,
respectively, are also conserved in EcMutY and BsMutY.
This suggests that F27 and R47 of Mig.MthI may not be
absolutely required for T/G or T/GO glycosylase activity.
Interestingly, Y112S TthMutY mutant lost the thymine
glycosylase activity supporting that Y126 of Mig.MthI may
be important for T/G catalytic activity. It remains to be
tested whether S120Y, Q25R, and L22F mutants of
EcMutY or in combination with V45A and Q182L can
gain T/G glycosylase activity.
V45A, Q182L, and V45A/Q182L EcMutY mutants cannot 
complement the mutY mutation
The reduced binding and glycosylase activities toward A/
G and A/GO of these EcMutY mutants led us to check
whether they have normal biological activity. We exam-
ined the mutation frequency in rifampicin forward-muta-
tion and Lac+ reversion assays. Rifampicin binds to RNA
polymerase (encoded by rpoB gene) and inhibits its tran-
scriptional function. Mutations in the rifampicin binding
site of RNA polymerase results in cells' resistance to
rifampicin. In the absence of both EcMutM and EcMutY, a
high level of rifampicin-resistant cells was observed (Table
3, left panel, line 2). The mutMmutY double mutant offers
a more sensitive complementation assay than the mutY
single mutant. Expression of wild-type EcMutY comple-
mented the mutMmutY  double mutation (Table 3, left
panel, line 4). Expression of EcMutY-V45A, EcMutY-
Q182L and EcMutY-V45A/Q182L mutants partially com-
plemented the deficient EcMutM and EcMutY function.
The mutation frequencies are 154, 44, and 178 folds
higher, respectively, compared to the CC104 wild-type
(Table 3, left panel, lines 1, 5–7).
CC104 strain was designed to screen G:C→T:A transver-
sions at an essential residue in the active site of β-galactos-
idase encoded by lacZ gene, thus it allowed us to measure
this type of mutation in EcMutY-V45A, EcMutY-Q182L
and EcMutY-V45A/Q182L mutants. Similar to the results
Table 2: Rate constants (K2) of MutY mutants.
DNA WT V45A Q182L V45A/Q182L
A/G 0.24 ± 0.03a 0.19 ± 0.03 (0.80)b 0.025 ± 0.016 (0.11) 0.032 ± 0.026 (0.14)
A/GO 2.4 ± 0.3 1.3 ± 0.1 (0.54) 0.16 ± 0.02 (0.07) 0.37 ± 0.05 (0.15)
ak2 values (Min-1) are means ± standard deviation for more than three experiments. k2 values with A/G and A/GO are determined at 37°C and 
20°C, respectively.
b The numbers in parenthesis are the folds of rate relative to wild-type (WT) MutY.BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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of rifampicin forward assay, the mutation frequency of the
mutMmutY  double mutant increased 400-fold over the
wild-type cells (Table 3, right panel, lines 1 and 2). The
EcMutY-V45A, EcMutY-Q182L and EcMutY-V45A/Q182L
mutants showed partial defect in preventing G:C→T:A
transversions as compared to the wild-type EcMutY.
Strains expressing V45A, Q182L and V45A/Q182L
mutants, respectively, showed 5, 8, and 17- fold higher
mutation frequencies than CC104 wild-type (Table 3,
right panel, lines 5–7). These increased G:C→T:A muta-
tion frequencies are in agreement with the reduced glyco-
sylase activities with A/G and A/GO mismatches in these
mutants.
Wild-type cells expressing the V45A mutant protein have 
an increased G:C to A:T mutation frequency
For the strains expressing V45A MutY protein, the
G:C→T:A mutation frequency measured by Lac+  reversion
assay was much lower than that measured by the
rifampicin forward-mutation assay (154 fold increase in
rifampicin forward-mutation assay vs. 5.3-fold increase in
the Lac+reversion assay) (Table 3, compare lines 5 in right
and left panels). Because V45A mutant exhibits milder
defect in adenine glycosylase activity than the other two
mutants, we suspected that the V45A mutant with a 1273-
fold increased T/G affinity (Table 1) might prevent T/G
mismatches from being repaired by other DNA repair
pathways. To test this idea, we isolated genomic DNA
from rifampicin resistant colonies from CC102 (mutM+
mutY+) cells expressing EcMutY-V45A and identified base-
base mutations of rpoB gene [25]. A significant increase in
G:C→A:T transition was found in cells expressing
EcMutY-V45A as compared to cells with vector alone
(Table 4). For unknown reason, the mutation frequency
of A:T to T:A was quite high in CC102 harboring vector
and EcMutY-V45A. CC102 strain was designed to screen
G:C→A:T transitions in lacZ gene. Thus, we further meas-
ured the G:C→A:T transition frequency by Lac+ reversion
assay in CC102 (mutM+ mutY+) strain expressing EcMutY-
V45A. The EcMutY-V45A expressing strain showed a 3.6-
fold higher Lac+ reversion frequency. A T-test of two sets of
data of rows 1 and 3 in Table 5 shows that this increase is
statistically significant with P = 0.001 (Table 5). These
data are consistent with our postulation that EcMutY-
V45A protein acts as a dominant-inhibitor of other DNA
repair pathways.
Conclusion
The substrate specificity of DNA glycosylases is very subtle
to the change of amino acids located in the DNA binding
pocket, and a single amino acid alteration may signifi-
cantly alter its enzyme activity. Our results show that V45
and Q182 of EcMutY are important for the binding affin-
ity and glycosylase activity to DNA containing A/G or A/
GO mismatches. The V45A/Q182L double mutant exhib-
ited an additive reduction in binding to both the A/G and
A/GO as for the single mutants. Our unexpected results
that EcMutY-V45A and EcMutY-Q182L show increased T/
G binding affinity without gaining T/G glycosylase indi-
cate the complicated nature of the DNA-enzyme interac-
tion.
Methods
Bacteria strains
Escherichia coli DH5α (F-, φ80-dlacZΔM15, endA1, recA1,
hsdR1, (rk
-mk
+), supE44, thi-1, gryA96(Nalr), relA1, Δ (lac-
ZYA-argF) U169) was purchased from Invitrogen. PR70
(Su- smrlacZ X74 galU galK miA68::Tn10kan) was obtained
from M. S. Fox. The miA68::Tn10kan allele in PR70 con-
tains a transposon at the mutY gene at nucleotide 747 and
Table 3: Mutation frequencies of λDE3-containing E. coli mutM mutY mutant strains.
Strain Mutation Frequency (RifR/108 cells) Fold Mutation frequency (Lac+/108 cells) Fold
1. CC104 (WT) 4.1 ± 1.3 1 1.2 ± 1.0 1
2. CC104 mutMmutY 1464 ± 314 357 486 ± 65 408
3. CC104M-Y- + pET11aa 2055 ± 704 501 156 ± 102 130
4. CC104M-Y- + pET-MutYb 8.8 ± 4.4 2 0.9 ± 0.8 0.8
5. CC104M-Y- + pET-V45Ac 630 ± 177 154 6.3 ± 2.1 5.3
6. CC104M-Y- + pET-Q182Ld 181 ± 74 44 10.2 ± 8.7 8.5
7. CC104M-Y- + pET-V45A/Q182Le 728 ± 358 178 20 ± 13 16.7
a The strain CC104 mutM mutY contains pET11a which is the expression vector for wild-type and mutant MutY expression. b-e The strain CC104 
mutM mutY expresses indicated MutY protein cloned in the pET11a vector.
Table 4: Mutation distribution of rpoB in λDE3-containing E. coli 
CC102 (mutM+mutY+) harboring pET11a and pET11a-V45A.
Plasmid No. of clones with rpoB mutation (%)
pET11a pET11a-V45A
A:T → T:A 30 (81.1)a 19 (61.3)
G:C → A:T 5 (13.5) 12 (38.7)
G:C → T:A 1 (2.7) 0 (0)
A:T → G:C 1 (2.7) 0 (0)
Total 37 31
aThe number in parenthesis are the percentages of each mutation 
type.BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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produces a truncated MutY protein [10]. CC102 [ara Δ
(lac-proB)XIII  thi  F'-lacI378 lacZ461 proA+B+) [26] and
CC104, which is identical to CC102 except for the muta-
tion at residue 461 of β-galactosidase, were generous gifts
from J. H. Miller. The derivative CC104 mutM mutY:
mutM::mini-kan  mutY::mini-Tn10 was also from J. H.
Miller. λDE3 lysogenic strains were constructed according
to the procedures described by Invitrogen. XL1-Blue
(recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F proAB
lacI, ZΔM15 Tn10 (Tet)]) was purchased from Stratagene.
Construction of E. coli mutY mutants
The mutant mutY  genes encoding proteins containing
V45A, Q182L and V45A/Q182L were constructed by the
QuickChange Site-Directed Mutagenesis Kit (Strategene).
The mutagenesis PCR primers for the desired amino acid
substitutions are listed below.
Chang564 5'-ATGTTGCAACAAACTCAAGCTGCGAC-
CGTTATCCCC-3'
Chang565 5'-GGGGATAACGGTCGCTGCTTGAGTTT-
GTTGCAACAT-3'
Chang566 5'-GTGGAACGGTTTAATCTGGCCATGAT-
GGATTTGGGTGCG-3'
Chang567 5'-CGCACCCAAATCCATCATGGCCAGAT-
TAAACCGTTCCAC-3'
Primers, Chang564 and Chang565, are designed for the
V45A mutant and Chang566 and Chang567 are designed
for the Q182L mutant using plasmid pMYW-1 [27] as the
template. The plasmids containing the mutY mutant genes
with V45A or Q182L mutation were named pMY-V45A
and pMY-Q182L. The double mutant was derived from
pMY-V45A using primers Chang566 and Chang 567. After
the PCR reaction, the template plasmids were digested
with DpnI restriction and transformed into XL1-Blue
supercompetent cells (Strategene). The correct clones
were confirmed by DNA sequencing.
Measurement of mutation frequency
Overnight cultures (0.1 ml) of each strain were plated on
LB agar plates containing 0.1 mg/ml rifampicin. The cell
titer of each culture was determined by plating 0.1 ml of
and 10-6 dilution onto LB agar plates. For each measure-
ment, four independent cultures were plated, and the
experiments were repeated at least three times. The muta-
tion frequency was determined by calculating the ratio of
Rifr cells to total cells. For LacZ+ reversion mutation assay,
overnight cultures (0.2 ml) of each strain were plated on
M9 agar plates containing 0.2% lactose and colonies were
scored after three days. The ratio of LacZ+ cells to total
CC104 cells was calculated to be the G:C→T:A transver-
sion frequency. The ratio of LacZ+ cells to total CC102
cells was calculated to be the G:C→A:T transition fre-
quency.
EcMutY protein expression and purification
E. coli strains PR70/DE3 harboring expression plasmids
pMY-V45A, pMY-Q182L, and pMY-V45A/Q182L were
grown in LB broth containing 50 μg/ml ampicillin at
37°C. At OD600  of 0.6, isopropyl β-D-thiogalactoside
(IPTG) was added to the culture to a final concentration
of 0.2 mM, and the culture was incubated at 20°C for 16
hrs. The EcMutY mutant proteins were purified by ammo-
nium sulfate precipitation, phosphocellulose, hydroxyla-
patite, heparin, Hitrap-S column chromatographies as
previously described for the wild-type MutY [21]. The
purified proteins were divided into small aliquots and
stored at -80°C. Protein concentration was determined by
Bradford Method.
Oligonucleotide substrates
The nucleotide sequences of 40-mer DNA substrates con-
taining mismatches used in this study were:
5'-AATTGGGCTCCTCGAGGAATTXGCCTTCTGCAG-
GCATGCC-3'
3'-CCCGAGGAGCTCCTTAAYCGGAAGACGTC-
CGTACGGGGCC-5'
(where X = A or T and Y = G or GO). The X-strand was
labeled by [γ-32p]ATP on the 5' end and then annealed
with the Y-strand. The annealed double-stranded oligonu-
cleotides were converted to 44-mers by filling the sticky
ends on both sides with Klenow fragment [28].
EcMutY binding and glycosylase assays
The EcMutY binding and glycosylase activities were
assayed as previously described by Lu et al [21]. The MutY
binding reaction mixture contained 20 mM Tris-HCl,
pH7.6, 80 mM NaCl, 1 mM dithiothreitol (DTT), 1 mM
EDTA, 2.9% glycerol, 20 ng of poly dI/dC, and 1.8 fmol of
labeled DNA (0.09 nM) in 20 μl reactions. After 30 min
incubation at 30°C, 3 μl of 50% glycerol was added to the
mixtures, and the samples were loaded to a 4% polyacry-
lamide gel in TBE buffer [50 mM Tris-borate (pH 8.3) and
Table 5: Lac+ reversion rate of λDE3-containing E. coli CC102 
(mutM+mutY+) strains
Mutation frequency
(Lac+/108 cells)
Fold
1. CC102 + pET11a 0.45 ± 0.12 1
2. CC102 + pET-MutY 0.51 ± 0.16 1.1
3. CC102 + pET-V45A 1.60 ± 0.36 3.6BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
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1 mM EDTA]. After electrophoresis, the gel was dried and
exposed to a PhosphorImager screen. Enzyme-bound and
free DNA bands were quantified on PhosphorImager and
analyzed by ImageQuant (GE Health). To determine
active site concentrations, binding experiments were per-
formed with 8 nM of A/GO-containing DNA for wild-
type, V45A, and Q182L EcMutY while 30 nM of the same
DNA was tested for the V45A/Q182L mutant. The MutY
concentrations used ranged from 2 to 400 nM as deter-
mined by the Bradford assay.
To determine the Kd  values, initially, wide ranges of
enzyme concentrations with 5-fold series dilution were
tested and then nine different enzyme concentrations
with 2-fold series dilution (four above and four below the
estimated Kd) were used. The experiments were repeated
at least three times. The Kd values were determined under
condition of ligand depletion by computer-fitted curve
generated by Graph Pad Prism version 3.03 (Graph Pad
Software, Inc) using Eq.1. The fraction of DNA bound to
protein (fbound) was plotted as a function of total active
protein concentration in each binding reaction ([P]active).
These data sets were then resolved by nonlinear regression
using equation 1, which incorporates ligand depletion
and returns the maximal binding fraction (fmax) and the
equilibrium dissociation constant (Kd). Fractional bind-
ing in the absence of protein (fmin) was set to 0 and the
concentration of DNA competent for binding in each
reaction is given by [DNA]T.
where b = Kd + [DNA]T + [P]active.
For Kd values without ligand depletion, Eq. 2 was used.
Under conditions where [DNA]T <<Kd (and hence [P]active-
total ≈ [P]active-free), plots of fbound versus [P]active were then
resolved by nonlinear regression using equation 2.
The glycosylase assay was carried out in a 10 μl reaction
containing 1.8 fmol of DNA substrate (0.18 nM), 20 mM
Tris-HCl (pH 7.6), 1 mM DTT, 1 mM EDTA, 2.9% glycerol
and 50 μg/ml of bovine serum albumin. After incubation
at indicated temperature for 30 min, reaction mixtures
were supplemented with 1 μl of 1 M NaOH and heated at
90°C for 30 min. Five μl of formamide dye (90% forma-
mide, 10 mM EDTA, 0.1% xylene cyanol, and 0.1%
bromophenol blue) was added to the sample and 5 μl
from this mixture was loaded onto a 14% polyacrylamide
sequencing gel containing 7 M urea. For time course stud-
ies, enzyme reaction was initiated at 37°C or at 4°C for A/
G or A/GO-containing DNA, respectively, and aliquot
taken at different time points were immediately frozen in
-70°C in the presence of 0.1 N NaOH, followed by heat-
ing at 90°C for 30 min before adding 5 μl formamide dye
and loading to 14% 7 M urea sequencing gels. Bands cor-
responding to cleavage products and intact DNA were
quantified from PhosphorImager images. Graphs and rate
constants of glycosylase activities are generated by Sigma-
Plot for Windows Version 10.0 (Systat Software, Inc.).
Sequencing of the rpoB gene
E. coli chromosomal DNA was isolated using a genomic
DNA purification kit (Gentra System, Minneapolis, MN).
The main group of mutations (cluster II) of the rpoB gene
was PCR amplified using primers Chang440 (5'-CGTCG-
TATCCGTTCCGTTGG-3') and Chang441 (5'-TTCAC-
CCGGATACATCTC GTC-3') as described and designed
previously [25]. The PCR product was purified with the
QIAquick PCR purification kit (QIAGEN, Valencia, CA)
and sequenced directly with Chang442 primer (5'-CGTG-
TAGAGCGTGCGGTGAAA-3').
Abbreviations
8-oxoG or GO: 7,8-dihydro-8-oxo-guanines; DTT: dithio-
threitol; EcMutY: Escherichia coli MutY; HhH: helix-hair-
pin-helix;  IPTG: isopropyl β-D-thiogalactoside;  k2: rate
constants; Kd: dissociation constant.
Authors' contributions
AL conceived the study with the participation of PC and
AM in the experimental design. PC carried out most of the
experiments and initial writing of the manuscript. AM per-
formed the active site titration experiments, analyzed the
dissociation constants, and edited the paper. AL revised
the manuscript that is then confirmed and approved by
other authors.
Acknowledgements
This work was supported by Public Health Service Grants GM 35132 and 
CA78391 from the National Institute of Health. We thank Drs. Maurice S. 
Fox and Jeffery H. Miller for providing E. coli strains. Special thanks to Dr. 
Eric Toth for his insightful discussion and effort to generate figure 2 and Dr. 
Gerald Wilson for his assistance in analysis of dissociation constants. We 
thank Bryan Dodson for critical reading of this manuscript.
References
1. Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellen-
berger T: DNA Repair and Mutagenesis Washington, D.C.: ASM Press;
2005. 
2. Krokan HE, Nilsen H, Skorpen F, Otterlei M, Slupphaug G: Base
excision repair of DNA in mammalian cells.  FEBS Lett 2000,
476:73-77.
3. Mol CD, Parikh SS, Putnam CD, Lo TP, Tainer JA: DNA repair
mechanisms for the recognition and removal of damaged
DNA bases.  Annu Rev Biophys Biomol Struct 1999, 28:101-128.
4. Lu A-L, Li X, Gu Y, Wright PM, Chang D-Y: Repair of oxidative
DNA damage: mechanism and functions.  Cell Biochem Biophy
2001, 35:141-170.
ff f f
bb active
bound min max min =+ − ×
−− ⎡
⎣
⎢
⎢
⎢
⎤
()
[] [ ]
[]
2 4
2
DNA T P
DNA T ⎦ ⎦
⎥
⎥
⎥
ff f f active
active K
bound min max min =+ − ×
+
⎡
⎣
⎢
⎤
⎦
⎥ ()
[]
[]
P
P dPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Biochemistry 2009, 10:19 http://www.biomedcentral.com/1471-2091/10/19
Page 11 of 11
(page number not for citation purposes)
5. Lu A-L, Bai H, Shi G, Chang D-Y: MutY and MutY homologs
(MYH) in genome maintenance.  Front Biosci 2006,
11:3062-3080.
6. Hazra TK, Hill JW, Izumi T, Mitra S: Multiple DNA glycosylases
for repair of 8-oxoguanine and their potential in vivo func-
tions.  Prog Nucleic Acid Res Mol Biol 2001, 68:193-205.
7. Michaels ML, Miller JH: The GO system protects organisms
from the mutagenic effect of the spontaneous lesion 8-
hydroxyguanine (7,8-dihydro-8-oxo-guanine).  J Bacteriol 1992,
174:6321-6325.
8. Tchou J, Grollman AP: Repair of DNA containing the oxida-
tively-damaged base 8-hydroxyguanine.  Mutat Res 1993,
299:277-287.
9. Blaisdell JO, Hatahet Z, Wallace SS: A novel role for Escherichia
coli endonuclease VIII in prevention of spontaneous G → T
transversions.  J Bacteriol 1999, 181:6396-6402.
10. Li X, Wright PM, Lu A-L: The C-terminal domain of MutY glyc-
osylase determines the 7,8-dihydro-8-oxo-guanine specificity
and is crucial for mutation avoidance.  J Biol Chem 2000,
275:8448-8455.
11. Gogos A, Cillo J, Clarke ND, Lu A-L: Specific recognition of A/G
and A/8-oxoG mismatches by Escherichia coli MutY:removal
of the C-terminal domain preferentially affects A/8-oxoG
recognition.  Biochemistry 1996, 35:16665-16671.
12. Manuel RC, Czerwinski EW, Lloyd RS: Identification of the struc-
tural and functional domains of MutY, an Escherichia coli
DNA mismatch repair enzyme.  J Biol Chem 1996,
271:16218-16226.
13. Manuel RC, Lloyd RS: Cloning, overexpression, and biochemi-
cal characterization of the catalytic domain of MutY.  Bio-
chemistry 1997, 36:11140-11152.
14. Noll DM, Gogos A, Granek JA, Clarke ND: The C-terminal
domain of the adenine-DNA glycosylase MutY confers spe-
cificity for 8-oxoguanine.adenine mispairs and may have
evolved from MutT, an 8-oxo-dGTPase.  Biochemistry 1999,
38:6374-6379.
15. Chmiel NH, Golinelli MP, Francis AW, David SS: Efficient recogni-
tion of substrates and substrate analogs by the adenine glyc-
osylase MutY requires the C-terminal domain.  Nucl Acids Res
2001, 29:553-564.
16. Guan Y, Manuel RC, Arvai AS, Parikh SS, Mol CD, Miller JH, Lloyd S,
Tainer JA: MutY catalytic core, mutant and bound adenine
structures define specificity for DNA repair enzyme super-
family.  Nat Struct Biol 1998, 5:1058-1064.
17. Fromme JC, Banerjee A, Huang SJ, Verdine GL: Structural basis for
removal of adenine mispaired with 8-oxoguanine by MutY
adenine DNA glycosylase.  Nature 2004, 427:652-656.
18. Manuel RC, Hitomi K, Arvai AS, House PG, Kurtz AJ, Dodson ML,
McCullough AK, Tainer JA, Lloyd RS: Reaction intermediates in
the catalytic mechanism of Escherichia coli MutY DNA glyc-
osylase.  J Biol Chem 2004, 279:46930-46939.
19. Horst JP, Fritz HJ: Counteracting the mutagenic effect of
hydrolytic deamination of DNA 5-methycytosine residues at
high temperature: DNA mismatch N-glycosylase Mig. Mth of
the thermophilic archaron Methanobacterium thermoau-
totrophicum THF.  EMBO J 1996, 15:5459-5469.
20. Fondufe-Mittendorf YN, Harer C, Kramer W, Fritz HJ: Two amino
acid replacements change the substrate preference of DNA
mismatch glycosylase Mig.MthI from T/G to A/G.  Nucl Acids
Res 2002, 30:614-621.
21. Lu A-L: Isolation and analyses of MutY and MutY homologs
(MYH).  Methods Enzymology 2006, 408:64-78.
22. Lu A-L, Fawcett WP: Characterization of the recombinant
MutY homolog, an adenine DNA glycosylase, from
Schizosacchromyces pombe.  J Biol Chem 1998, 273:25098-25105.
23. Mol CD, Arvai AS, Begley TJ, Cunningham RP, Tainer JA: Structure
and activity of a thermostable thymine-DNA glycosylase:
evidence for base twisting to remove mismatched normal
DNA bases.  J Mol Biol 2002, 315:373-384.
24. Back JH, Park JH, Chung JH, Kim DS, Han YS: A distinct TthMutY
bifunctional glycosylase that hydrolyzes not only adenine but
also thymine opposite 8-oxoguanine in the hyperther-
mophilic bacterium, Thermus thermophilus.  DNA Repair
(Amst) 2006, 5:894-903.
25. Kim M, Huang T, Miller JH: Competition between MutY and
mismatch repair at A·C mispair in vivo.  J Bacteriol 2003,
185:4626-4629.
26. Cupples CG, Miller JH: A set of lacZ mutations in Escherichia coli
that allow rapid detection of each of the six base substitu-
tions.  Proc Natl Acad Sci USA 1989, 86:5345-5349.
27. Wright PM, Yu J, Cillo J, Lu A-L: The active site of the Escherichia
coli  MutY DNA adenine glycosylase.  J Biol Chem 1999,
274:29011-29018.
28. Lu A-L: Repair of A/G and A/8-oxoG mismatches by MutY
adenine DNA glycosylase.  In DNA Repair Protocols: Prokaryotic Sys-
tems Edited by: Vaughan P. Totowa, NJ: Humana Press Inc; 2000:3-16. 